CONTROLLED AI / LIFE SCIENCES / GxP COMPLIANCE

More intelligence.
Every decision
still yours.

Research FDA, ICH, EU GMP and other regulatory sources alongside your SOPs. Develop quality documents and validation evidence with human review, approvals, and authorship history.

Life Sciences Compliance Platform

QUALISERA / WORKSPACEProduct screenshot
Qualisera workspace with Regulatory Intelligence, Enforcement Intelligence, Document Studio, Test Management System, and CRDM marked Coming soon.

RegLens and TMS from one workspace. CRDM is in development.

View full-size screenshot
Sources you can inspect Decisions your team owns A history you can follow

SPECIALIST TOOLS / ONE CONTROLLED APPROACH

Built for the work.
Accountable to your team.

Regulatory work and validation have different needs. Start with the product that fits the task, with human judgment at the center of both.

Explore in a demo

REGULATORY & QUALITY DOCUMENTS

RegLens

Find the regulatory basis. Develop a draft. Review it against named sources.

  • Cited regulatory research and document review
  • Enforcement precedent kept distinct from regulation
  • Versioned agents for department standards
Explore RegLens
Explore in a demo

VALIDATION & TEST MANAGEMENT

TMS

Connect requirements, test protocols, execution, and the people responsible for approval.

  • Specifications and AI-assisted test drafting
  • Requirement-to-test traceability
  • Review, approval, and execution records
Explore TMS

REGLENS AGENTS / CONSISTENCY WITH CONTEXT

Make every
AI run count.

Put every AI run to work with a shared standard, a reviewer, and a record.

Use versioned references and document structures to support more consistent AI-assisted deliverables. Keep review decisions traceable, with audit trails and authorship reports that make contributions visible.

01 Define the standard02 Review the output03 Retain the history
Explore RegLens Agents

A shared standard makes review clearer across repeated work.

REGULATORY CONTEXT / YOUR DOCUMENTS / VISIBLE REVIEW

Specialist sources.
Your standards. Your decisions.

Bring the references and document controls your quality team works with into each AI-assisted workflow.

01 / REGULATORY SOURCES

Research the rules themselves.

FDA · ICH · EU GMP · MHRA · PMDA (Japan) · Health Canada · NIST

Open the supporting source and section alongside an answer. Keep regulations, guidance, and internal documents identifiable.

02 / GOVERNING DOCUMENTS

Start from your own standard.

Select governing SOPs, policies, and templates for a draft. Work with an organization-scoped library of documents alongside the regulatory sources.

03 / REVIEW & AUTHORSHIP

Keep the decision with the work.

Accept, edit, or decline proposals. Follow the author, revision, and review decision through audit history and authorship reports.

04 / MODEL CHOICE

Choose how your work is processed.

Draft and review with Anthropic or OpenAI. Using your own model agreement, such as Azure OpenAI, is scoped to your engagement.

Explore the workflow controls ↗

START WITH YOUR TEAM’S TASK

Recognizable work.
Clearer next steps.

BUILT FROM EXPERIENCE IN GxP

The work should
have better tools.

Qualisera brings experience in pharmaceutical and medical device quality systems to the design of practical software for regulated work.

Meet the people behind Qualisera ↗

CUSTOM SOLUTIONS / SCOPED TO YOUR WORK

A workflow beyond
the standard tools?

Discuss domain agents, document structures, and connections to your existing systems. Start with the task, the sources, and the controls your team needs.

Discuss a custom workflow ↗

SEE IT IN YOUR WORKFLOW

Bring a real problem.
Explore the fit.

Walk through a regulatory or validation workflow. See where AI assists, how your team reviews, and what evidence remains.

Discuss your workflow ↗

ILLUSTRATIVE SOURCE / FICTIONAL CONTENT

ACME-QM-001 Quality Manual

Section 5.0 · Quality Unit responsibilities

The Quality Unit reviews and approves the classification, investigation, and closure of every deviation.

Acme Biologics is a fictional company. This passage demonstrates how a cited source opens beside the work; it is not a real procedure or regulatory advice.